Super.com logo
Super.com Financial Model

Biotech/Pharma Startup Financials (Free Excel Download)

Super is a savings super app targeting low-income Americans, offering hotel discounts, cashback rewards (SuperCash), credit building, gas savings, phone plans, insurance, and pharmacy deals in one app.

Loading...

Used by professionals from

KPMG logoWharton logoColumbia logoESSEC logoPwC logoHEC logo

About this model

Super is a savings app for lower-income Americans, combining discounted hotels, SuperCash prepaid-card rewards, credit building, gas, phone, insurance, pharmacy, cashback, and grocery offers. Personalised app layouts and higher-frequency products aim to make the service habitual rather than dependent on occasional hotel bookings.

Revenue is inferred from travel commissions, card interchange, credit-building fees, and affiliate or partner commissions. The business reports roughly $1 billion of annualised GMV, with some commissions passed through as customer rewards; net revenue therefore depends on take rates, reward funding, active users, and category mix.

Super had more than 80 million registered users, $150 million-plus raised, $150 million-plus in delivered savings, about 80% gross margin, and net-revenue CAGR near 100% from 2018–22. The model should forecast active users, GMV, commissions, card economics, rewards, CAC, and retention.

A turnkey financial model

Live formulas, no hardcoded values

Outputs are driven by live formulas, so the workbook updates from its assumptions instead of relying on hardcoded results.

All assumptions in one tab

Inputs are clearly marked in the Assumptions tab and separated from calculations, making it clear what to change and what to leave intact.

Statements always balancing

For integrated-statement models, the balance sheet, cash flow, and supporting schedules tie through properly.

Distinct schedules for clarity

Debt, working capital, taxes, and cash flow can get messy quickly. We group calculations in clear schedules, not across disconnected tabs.

No hidden macros or external links

There are no unexplained external workbook links or macros to undermine auditability or portability.

Changes flow through the model

Update a key driver and see the impact carry through the forecast, financing, and return outputs. We never use hardcoded numbers in formulas.

About Super.com

super.com
Read the pitch deck
Super.com pitch deck cover
View on makeslides.com
Total raised
$60.0M
Funding round
Series C
Founded
2023
Category
Biotech/Pharma
Customer
B2C
Geography
United States

How to build a detailed financial model for Super.com

A complete walkthrough of the business, drivers, and assumptions behind the downloadable Super.com model - distilled from its pitch deck and publicly available information.

Product & value proposition

  • Core promise: help everyday Americans (HHI <$50K, low/no credit score) spend less, access credit, and experience more.
  • Products in the app (active or planned):
  • Hotels / travel (discount booking) - core product at launch
  • SuperCash (prepaid/debit card + rewards wallet) - described as "core to the experience" and the flywheel anchor
  • Credit building
  • Gas savings
  • Phone plans (20–40% off monthly plan)
  • Insurance (pay-per-mile)
  • Pharmacy discounts
  • Shop (cashback, gift cards, card-linked offers)
  • Grocery (local flyers, in-store coupons)
  • Personalization: dynamic UI adapts layout/content to user behavior (travel-focused, cash-focused, dropped-off, etc.)
  • Frequency strategy: expansion into daily/weekly use cases (gas, grocery, cash) to move out of the "forgettable zone" of hotel-only (bi-annual) frequency

Market

  • Total addressable consumer pool: 183M consumers identified
  • Secondary segment: 100M consumers - low/med income ($50K–$75K HHI), FICO >669
  • Core target (SAM): 83M consumers - Gen X & Gen Y (age 25–56), HHI <$50K, FICO <669 or no score
  • Customer behavioral stats: 41% have to save before they buy; 2% wait for products to go on sale

Revenue model

  • Primary revenue streams (inferred from product mix; not broken out explicitly):
  1. Travel/hotel commissions - booking margin on discounted hotel inventory
  2. SuperCash card economics - interchange fees and/or spread on prepaid card transactions
  3. Financial product fees - credit-building subscription or fee
  4. Affiliate/partner commissions - gas, pharmacy, phone plans, shop cashback (pass-through structure mentioned: "pass all the commission to user" for some categories, implying retained margin on others)
  • GMV-based business: reports ~$1B annualized GMV; net revenue is a take-rate on top of that
  • Take-rate implied: ~$1B GMV vs. net revenue growing at ~100% CAGR - absolute 2022 net revenue figure not stated on bar chart but bars show steep growth 2018–2022
  • Pricing to consumer: savings-first; SuperCash rewards passed through to users as rebate/cashback

Traction & metrics

  • Launched: ~6 years ago (from deck date, implying ~2016–2017)
  • Registered users: 80M+
  • Annualized GMV: ~$1B
  • Net revenue CAGR 2018–2022: ~100%
  • Capital raised to date: $150M+
  • Direct savings delivered to customers: $150M+
  • Gross margin: ~80%
  • Absolute net revenue figures by year: not labeled on bar chart - bars show accelerating growth from 2018A through 2022A
  • Team size: 223 full-time

Unit economics

  • Gross margin: ~80%
  • Payback: customers payback gross profit on their first transaction
  • LTV:CAC at first transaction (GP basis): ~2x
  • LTV:CAC over 36 months (GP basis): 4x+ estimated
  • Cohort trend: consistently improving GP LTV:CAC across customer cohorts

Competition / moat

  • Not addressed directly in deck
  • Implied moats:
  • 80M+ user base (distribution scale)
  • SuperCash flywheel: travel/shop transaction history feeds personalized savings suggestions, increasing engagement and retention
  • Data moat: transaction history enables targeting of financial products (credit building, insurance)
  • Mission-fit brand targeting underserved segment with limited alternatives

Team & funding ask / use of funds

  • Co-founders:
  • Hussein Fazal - Co-Founder & CEO (previously AdParlor)
  • Henry Shi - Co-Founder & COO (previously LendUp, Google)
  • Key executives: Radhika Duggal (CMO, ex-Chase/CommonBond), Daniel Weisenfeld (CFO, ex-BofA Securities)
  • Independent board: Clem Bason (ex-Hotwire), Rick Galasieki (ex-Green Dot/MetaBank), Eitan Sisso (GM SuperShop/DailySteals), Kevin Keller (ex-Amazon General Counsel), Joanne Bradford (ex-COO/CMO SoFi), Anan Kashyap (ex-CFO Poshmark)
  • Raise: $60M Series C
  • Use of funds: grow existing savings use cases; expand into new use cases
  • Prior capital raised: $150M+

Recommended financial model

  • Archetype + why: Multi-product consumer marketplace / fintech super app model. Super has two intertwined revenue engines: (1) a marketplace/affiliate GMV layer (travel, shop, gas, pharmacy) with a commission take-rate, and (2) a fintech card/credit layer (SuperCash interchange, credit-building fees). The right archetype is a GMV take-rate + fintech fee 3-statement model, similar to a neobank-meets-OTA hybrid. A pure SaaS ARR model does not fit (no subscription base stated). A DTC inventory model does not fit (asset-light bookings). The GMV + attached financial products structure mirrors companies like Honey/Rakuten (commerce) + Chime (fintech).
  • Forecast horizon & granularity: 5 years (2023–2027), annual columns with monthly detail for Year 1 only. Deck is Series C, so investors need a 3–5 year path to scale/profitability.
  • Key drivers & assumptions:
DriverValueSource
Registered user base (2022 base)80M+-
Annualized GMV (2022)~$1B-
Net revenue CAGR 2018–2022~100%-
Gross margin~80%-
GP LTV:CAC at first transaction~2x-
GP LTV:CAC over 36 months4x+-
Series C raise$60M-
Net revenue growth post-raise (Yr 1)~60–80%step-down from ~100% CAGR as base grows; Series C capital deployment accelerates new verticals
Net revenue growth (Yr 2–3)~40–60%maturation of travel + ramp of SuperCash and credit products
Net revenue growth (Yr 4–5)~25–35%large base, product mix shift toward higher-margin fintech
Blended take-rate on GMV~10–15%implied by ~$1B GMV and a high-growth net revenue line; consistent with OTA/marketplace comps
GMV growth rate~50–70%lags net revenue growth as new product lines (fintech, phone, grocery) add net revenue with lower GMV
Gross margin (stable)~80%high-quality signal; typical of software/marketplace with minimal COGS
S&M as % of revenue (Year 1)~50–60%growth-stage consumer fintech; fast CAC payback (first transaction) supports aggressive spend
S&M as % of revenue (Year 5)~25–30%leverage as cohorts mature and cross-sell from existing 80M users reduces blended CAC
R&D as % of revenue~15–20%multi-product platform with active roadmap (grocery, insurance, gaming)
G&A as % of revenue~10–12%223 FTE; remote-first keeps real estate low
EBITDA breakevenYear 3–4typical Series C consumer fintech trajectory at this growth rate
New users added annually (base case)15–20Mimplied by reaching 80M over ~6 years; $60M raise accelerates UA
Monthly active rate on registered base~15–25%marketplace/app comps; actual MAU not disclosed
SuperCash card ARPU contribution~$20–40/yr per active cardholderinterchange-driven; benchmarked against prepaid/neobank comps
Credit building fee~$5–10/mo per subscriberconsistent with Self/Credit Karma secured card comps
  • Scenarios (Base / Bull / Bear - which variables flex):
  • Bear: Net revenue growth steps down to 30–40% post-Series C (macro headwinds on low-income consumers; competitive pressure from Rakuten/Capital One Shopping); gross margin compresses to ~70% as fintech products scale; breakeven pushed to Year 5.
  • Base: ~60–80% growth Year 1 stepping to ~30% by Year 5; gross margin holds ~80%; EBITDA positive Year 3–4; SuperCash and credit products begin contributing meaningfully by Year 2.
  • Bull: 100%+ growth continues 1–2 more years (new verticals ignite fast); GMV reaches $3–4B by 2025; fintech products achieve 30%+ of net revenue mix at higher margins; EBITDA positive Year 2–3.
  • Flex variables: user growth rate, MAU%, blended take-rate, S&M efficiency (CAC), fintech product adoption rate.
  • Required sheets / outputs:
  1. Assumptions - all drivers centralized with scenario toggle (Base/Bull/Bear)
  2. User Cohorts - new user additions by year, active rate, revenue per active user by product
  3. GMV & Revenue Build - GMV by vertical (travel, shop, gas, grocery, etc.) × take-rate → net revenue
  4. Fintech Revenue Build - SuperCash cardholders × ARPU + credit subscribers × monthly fee
  5. P&L (Income Statement) - net revenue → gross profit → EBITDA → net income; 2023–2027 annual
  6. Opex Detail - S&M (CAC × new users + retention spend), R&D, G&A
  7. Unit Economics Summary - blended CAC, GP at first transaction, LTV:CAC at 12/24/36 months, payback period
  8. Cash & Runway - opening cash + $60M raise, quarterly burn, runway to breakeven
  9. Dashboard - GMV, net revenue, gross margin %, EBITDA, users, LTV:CAC; Base vs. Bull vs. Bear toggle

Frequently asked

Is the Super.com financial model free?+

Yes. The Super.com model is a free Excel (.xlsx) download with live formulas. Sign up with your email and the workbook is yours to keep, review, and edit.

What's included in the model?+

A 5-year monthly forecast with P&L, cash flow and runway, valuation (exit multiple plus a DCF cross-check), MOIC/IRR returns, and unit economics, with live formulas throughout.

How was this model built?+

It was built from Super.com's pitch deck and publicly available information, then structured to investment-banking standards as a fully editable Excel model.

Can I change the assumptions?+

Yes. You can change assumptions and the live formulas will recalculate in the downloadable Excel model.

Have more financial modelling questions? Contact us

Alex Tapio, ex-Deloitte financial modelling expert

Created by ex-finance professionals

Hey, I’m Alex and I created Finamodel.

Over my years in the finance industry I kept building the same models over and over again. Same structure, same assumptions, different logo. So I started building frameworks to turn them into clean, reusable templates.

Every model here is one I’d actually use for a client, and I personally vet each one before it goes up.

I’m not an expert in every industry, but I’ve built enough models to know what belongs in one. And when something is completely foreign to me, I reach out to my network for experts to work on our models with us.

Having a template library on hand cuts a first build from hours to minutes.

Need help finding your model? You’ll find me in the Finamodel app!

Other Biotech/Pharma Startup Financial Models

Browse another startup in the same category.

ada-health.xlsx
Metric
2026
2027
Revenue
--
--
EBITDA
--
--
Ada Health logo

Ada Health

AI-powered symptom assessment app and clinical decision-support platform for consumers and healthcare partners.

affini-t.xlsx
Metric
2026
2027
Revenue
--
--
EBITDA
--
--
AF

Affini-T

Engineered T cell therapies targeting oncogenic driver mutations (KRAS, p53) in hard-to-treat solid tumors

alto-pharmacy.xlsx
Metric
2026
2027
Revenue
--
--
EBITDA
--
--
Alto Pharmacy logo

Alto Pharmacy

Alto Pharmacy is a tech-enabled, same-day prescription delivery pharmacy disrupting the $450B US pharmacy market via a direct-to-patient courier model and provider-facing software platform.

apheabio.xlsx
Metric
2026
2027
Revenue
--
--
EBITDA
--
--
Aphea.Bio logo

Aphea.Bio

Aphea.Bio is a Belgian ag-biotech company developing and commercialising microbial biologicals (biostimulants, biofungicides, bioherbicides, bioinsecticides) for row crops, targeting yield improvement and reduced synthetic input use.

aurion-biotech.xlsx
Metric
2026
2027
Revenue
--
--
EBITDA
--
--
Aurion Biotech logo

Aurion Biotech

Cell therapy company developing an injectable corneal endothelial cell treatment to restore vision in patients with corneal endothelial disease.

beckley-psytech.xlsx
Metric
2026
2027
Revenue
--
--
EBITDA
--
--
Beckley Psytech logo

Beckley Psytech

Clinical-stage psychedelic drug development platform advancing a pipeline of psychedelic compounds (psilocybin, 5-MeO-DMT, NCEs) as licensed pharmaceutical medicines for neuropsychiatric disorders.

brightinsight.xlsx
Metric
2026
2027
Revenue
--
--
EBITDA
--
--
BrightInsight logo

BrightInsight

Regulated digital health platform-as-a-service for biopharma and medtech companies to build, launch, and maintain compliant connected-drug and medical-device software products.

carrum-health.xlsx
Metric
2026
2027
Revenue
--
--
EBITDA
--
--
CH

Carrum Health

Value-based care marketplace connecting self-insured employers to top-tier surgical and oncology Centers of Excellence (COEs) via all-inclusive bundled payments.

Go further

Build the financial model you need with Fina

Browse templates, examples, and downloadable Excel models for the analysis you are trying to build. If you can't find your model, ask Fina to build a model for your specific needs.

Start for free
Excel financial model spreadsheet preview showing Customer Rollforward
Fina interactive chat interface preview